Neutrophils in cancer

Louise W Treffers, Ida H Hiemstra, Taco W. Kuijpers, Timo K van den Berg, Hanke L Matlung

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Neutrophils play an important role in cancer. This does not only relate to the well-established prognostic value of the presence of neutrophils, either in the blood or in tumor tissue, in the context of cancer progression or for the monitoring of therapy, but also to their active role in the progression of cancer. In the current review, we describe what is known in general about the role of neutrophils in cancer. What is emerging is a complex, rather heterogeneous picture with both pro- and anti-tumorigenic roles, which apparently differs with cancer type and disease stage. Furthermore, we will discuss the well-known role of neutrophils as myeloid-derived suppressor cells (MDSC), and also on the role of neutrophils as important effector cells during antibody therapy in cancer. It is clear that neutrophils contribute substantially to cancer progression in multiple ways, and this includes both direct effects on the cancer cells and indirect effect on the tumor microenvironment. While in many cases neutrophils have been shown to promote tumor progression, for instance by acting as MDSC, there are also protective effects, particularly when antibody immunotherapy is performed. A better understanding of the role of neutrophils is likely to provide opportunities for immunomodulation and for improving the treatment of cancer patients.

Original languageEnglish
Pages (from-to)312-28
Number of pages17
JournalImmunological Reviews
Volume273
Issue number1
DOIs
Publication statusPublished - Sep 2016

Cite this

Treffers, L. W., Hiemstra, I. H., Kuijpers, T. W., van den Berg, T. K., & Matlung, H. L. (2016). Neutrophils in cancer. Immunological Reviews, 273(1), 312-28. https://doi.org/10.1111/imr.12444
Treffers, Louise W ; Hiemstra, Ida H ; Kuijpers, Taco W. ; van den Berg, Timo K ; Matlung, Hanke L. / Neutrophils in cancer. In: Immunological Reviews. 2016 ; Vol. 273, No. 1. pp. 312-28.
@article{40aad0df788f47b4ab9bdd69ac0530a4,
title = "Neutrophils in cancer",
abstract = "Neutrophils play an important role in cancer. This does not only relate to the well-established prognostic value of the presence of neutrophils, either in the blood or in tumor tissue, in the context of cancer progression or for the monitoring of therapy, but also to their active role in the progression of cancer. In the current review, we describe what is known in general about the role of neutrophils in cancer. What is emerging is a complex, rather heterogeneous picture with both pro- and anti-tumorigenic roles, which apparently differs with cancer type and disease stage. Furthermore, we will discuss the well-known role of neutrophils as myeloid-derived suppressor cells (MDSC), and also on the role of neutrophils as important effector cells during antibody therapy in cancer. It is clear that neutrophils contribute substantially to cancer progression in multiple ways, and this includes both direct effects on the cancer cells and indirect effect on the tumor microenvironment. While in many cases neutrophils have been shown to promote tumor progression, for instance by acting as MDSC, there are also protective effects, particularly when antibody immunotherapy is performed. A better understanding of the role of neutrophils is likely to provide opportunities for immunomodulation and for improving the treatment of cancer patients.",
keywords = "Journal Article, Review",
author = "Treffers, {Louise W} and Hiemstra, {Ida H} and Kuijpers, {Taco W.} and {van den Berg}, {Timo K} and Matlung, {Hanke L}",
note = "{\circledC} 2016 The Authors. Immunological Reviews published by John Wiley & Sons Ltd.",
year = "2016",
month = "9",
doi = "10.1111/imr.12444",
language = "English",
volume = "273",
pages = "312--28",
journal = "Immunological Reviews",
issn = "0105-2896",
publisher = "Wiley-Blackwell",
number = "1",

}

Treffers, LW, Hiemstra, IH, Kuijpers, TW, van den Berg, TK & Matlung, HL 2016, 'Neutrophils in cancer' Immunological Reviews, vol. 273, no. 1, pp. 312-28. https://doi.org/10.1111/imr.12444

Neutrophils in cancer. / Treffers, Louise W; Hiemstra, Ida H; Kuijpers, Taco W.; van den Berg, Timo K; Matlung, Hanke L.

In: Immunological Reviews, Vol. 273, No. 1, 09.2016, p. 312-28.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Neutrophils in cancer

AU - Treffers, Louise W

AU - Hiemstra, Ida H

AU - Kuijpers, Taco W.

AU - van den Berg, Timo K

AU - Matlung, Hanke L

N1 - © 2016 The Authors. Immunological Reviews published by John Wiley & Sons Ltd.

PY - 2016/9

Y1 - 2016/9

N2 - Neutrophils play an important role in cancer. This does not only relate to the well-established prognostic value of the presence of neutrophils, either in the blood or in tumor tissue, in the context of cancer progression or for the monitoring of therapy, but also to their active role in the progression of cancer. In the current review, we describe what is known in general about the role of neutrophils in cancer. What is emerging is a complex, rather heterogeneous picture with both pro- and anti-tumorigenic roles, which apparently differs with cancer type and disease stage. Furthermore, we will discuss the well-known role of neutrophils as myeloid-derived suppressor cells (MDSC), and also on the role of neutrophils as important effector cells during antibody therapy in cancer. It is clear that neutrophils contribute substantially to cancer progression in multiple ways, and this includes both direct effects on the cancer cells and indirect effect on the tumor microenvironment. While in many cases neutrophils have been shown to promote tumor progression, for instance by acting as MDSC, there are also protective effects, particularly when antibody immunotherapy is performed. A better understanding of the role of neutrophils is likely to provide opportunities for immunomodulation and for improving the treatment of cancer patients.

AB - Neutrophils play an important role in cancer. This does not only relate to the well-established prognostic value of the presence of neutrophils, either in the blood or in tumor tissue, in the context of cancer progression or for the monitoring of therapy, but also to their active role in the progression of cancer. In the current review, we describe what is known in general about the role of neutrophils in cancer. What is emerging is a complex, rather heterogeneous picture with both pro- and anti-tumorigenic roles, which apparently differs with cancer type and disease stage. Furthermore, we will discuss the well-known role of neutrophils as myeloid-derived suppressor cells (MDSC), and also on the role of neutrophils as important effector cells during antibody therapy in cancer. It is clear that neutrophils contribute substantially to cancer progression in multiple ways, and this includes both direct effects on the cancer cells and indirect effect on the tumor microenvironment. While in many cases neutrophils have been shown to promote tumor progression, for instance by acting as MDSC, there are also protective effects, particularly when antibody immunotherapy is performed. A better understanding of the role of neutrophils is likely to provide opportunities for immunomodulation and for improving the treatment of cancer patients.

KW - Journal Article

KW - Review

U2 - 10.1111/imr.12444

DO - 10.1111/imr.12444

M3 - Article

VL - 273

SP - 312

EP - 328

JO - Immunological Reviews

JF - Immunological Reviews

SN - 0105-2896

IS - 1

ER -